Commentary on “Correlation between weight loss and testosterone restoration after sleeve gastrectomy in patients with biochemical male obesity-associated secondary hypogonadism”

作者
Michał Rabijewski,Jakub Wydra,Marcin Rabijewski
出处
期刊:Asian Journal of Andrology [Medknow]
卷期号:28 (5): 697-698
标识
DOI:10.4103/aja2025118
摘要

Obesity stands as a main public health challenge in the recent century. The World Obesity Atlas 2024 projected that by 2035, more than 1.5 billion adults globally will be overweight or obese. Obesity is strongly related to many comorbid conditions like metabolic syndrome, non-alcoholic fatty liver disease, diabetes, cardiovascular disease, and obstructive sleep apnea. The latest epidemiological data indicate that the prevalence of overweight and obesity was almost 2 times higher in men than that in women of all ages, especially in reproductive age. They cause endocrine disorders, negatively affect reproductive capacity, and are a risk factor for associated comorbidities leading to increased mortality. Therefore, it is currently extremely important to prevent obesity and treat it effectively.1 A very common and significant consequence of obesity in men is male obesity-associated secondary hypogonadism (MOSH). Its symptoms include reduced muscle and bone mass, sexual dysfunction, decreased quality of life, and an increased risk of prediabetes, type 2 diabetes, and metabolic syndrome.2 In the recent article of the Asian Journal of Andrology, Zhao et al.3 presented the efficacy of laparoscopic sleeve gastrectomy (LSG) on MOSH remission and testosterone levels and explored the associations between weight loss and serum testosterone levels changes. This retrospective study was conducted in 186 patients with a mean age of 33.1 years and a mean body mass index (BMI) of 43.0 kg m−2. MOSH remission rates at 12 months and 24 months post-LSG were 79.7% and 89.5%, respectively, accompanied by substantial increases of total testosterone levels (from 7.0 nmol l−1 to 18.4 nmol l−1) and free testosterone levels (from 0.2 nmol l−1 to 0.4 nmol l−1) at respective time points. Total weight loss percentage (TWL%) reached 34.4% and 32.3% at respective time points. Men with MOSH had luteinizing hormone (LH; 5.1 IU l−1) and follicle-stimulating hormone (FSH; 4.2 IU l−1) concentrations within the normal range before treatment and they did not change after 24 months, while estradiol levels decreased from 146.0 pmol l−1 to 118.2 pmol l−1. On the one hand, the results obtained are extremely spectacular and prove that testosterone deficiency in men with obesity can be effectively treated surgically, but on the other hand, they raise a few questions. MOSH, often called functional hypogonadism (FH), is caused by obesity, age, exercise, stress, drugs, co-occurring diseases, and opioids; and in approximately 30% of cases, the cause is unknown.4 FH is defined as the coexistence of low testosterone and signs of hypogonadism occurring in the absence of structural pathology of hypothalamic-pituitary-testis (HPT) axis. So the main role is attributed to partial suppression of hypothalamic and pituitary function caused by excess estradiol produced by aromatization in adipocytes. Other mechanisms that impair gonadotropin-releasing hormone (GnRH) secretion (through kisspeptin suppression) include insulin and leptin resistance, and proinflammatory cytokines.4 However, the authors did not observe a reduction in gonadotropin secretion in men with obesity (despite low testosterone levels), and these levels did not increase after surgery. Whereas, estradiol levels were significantly reduced after treatment. We also know that obesity is associated with low sex hormone binding globulin (SHBG) levels, and these levels increased after surgery. Increasing SHBG levels can, in turn, result in decreased free testosterone levels. However, in the study cohort, free testosterone levels also increased significantly. The hormonal changes described by the authors after surgical treatment indicate that the pathomechanism of testosterone deficiency in men with obesity is complex and the specific causes are not fully understood. But, the fact that bariatric treatment leads to the resolution of MOSH is extremely important for the health of men with obesity. It should be emphasized, however, that hypogonadism in men, regardless of the cause, is a coincidence of low testosterone levels and clinical symptoms. Although the authors of the discussed studies did not evaluate these symptoms (which were usually nonspecific), it appears that increasing testosterone levels in these patients must have had a beneficial effect on their well-being, quality of life, and sexual activity, and not just reduced the risk of metabolic disorders. Weight loss likely also has a beneficial effect on male fertility. According to the European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males, the diagnosis of functional hypogonadism is based on the presence of clinical symptoms of testosterone deficiency in combination with low serum testosterone levels, and after exclusion of organic causes of hypogonadism.5 In men with MOSH and a BMI >40 kg m−2, bariatric surgery seems to be the most effective method,6 but the first-line treatment should be lifestyle changes, physical exercise, modification of drugs (e.g., opiates and anabolic steroids), and treatment of chronic diseases. FH (also MOSH) can be diagnosed after excluding primary and secondary hypogonadism, and after eliminating the factors causing androgen deficiency. Testosterone replacement therapy is not the treatment of choice for weight loss, and is contraindicated in men who desire fertility. COMPETING INTERESTS All authors declare no competing interests.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
wanci的应助被我在RB种土豆采纳,获得10
刚刚
biu完成签到 ,获得积分10
1秒前
justin完成签到,获得积分10
1秒前
2秒前
viscabarca完成签到,获得积分10
3秒前
3秒前
咩了个咩发布了新的文献求助10
3秒前
3秒前
4秒前
学术雷锋发布了新的文献求助10
4秒前
5秒前
Juvenilesy的应助被HONGZ采纳,获得10
5秒前
5秒前
xing发布了新的文献求助10
5秒前
Yuenna发布了新的文献求助10
5秒前
6秒前
wanci的应助被kk采纳,获得10
6秒前
6秒前
DOC_XIONG的应助被寒冷书兰采纳,获得10
6秒前
拉拉啊了完成签到,获得积分10
6秒前
7秒前
7秒前
罗鑫发布了新的文献求助10
8秒前
小马甲的应助被shanguren采纳,获得10
8秒前
江边拔草完成签到,获得积分10
8秒前
曹牛牛发布了新的文献求助10
10秒前
完美世界的应助被咩了个咩采纳,获得10
10秒前
可耐的稀发布了新的文献求助10
10秒前
10秒前
ddddd完成签到,获得积分10
10秒前
后悔体验生活的北极兔完成签到,获得积分20
10秒前
lin发布了新的文献求助10
10秒前
10秒前
molihuakai的应助被舒适念真采纳,获得10
11秒前
嘻嘻哈哈发布了新的文献求助10
11秒前
烟花的应助被Yuenna采纳,获得10
11秒前
11秒前
11秒前
拉拉啊了发布了新的文献求助10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161320
求助须知:如何正确求助?哪些是违规求助? 9556074
关于积分的说明 21732157
捐赠科研通 7751456
什么是DOI,文献DOI怎么找? 3427537
关于科研通互助平台的介绍 2552583
邀请新用户注册赠送积分活动 2471992